01 / Vendor Profile
NEW YORK GENOME CENTER, INC. Federal Contracts and Awards
UEI WKPTJDWG2C68 · CAGE 5P5D4
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $37.82M in net contract obligations to NEW YORK GENOME CENTER, INC. across 57 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
NEW YORK GENOME CENTER, INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations-$2.96M
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $1.01M | 3 | 2 | — |
| FY 2021 | $5.83M | 6 | 2 | +479.1% |
| FY 2022 | $113.4K | 2 | 1 | −98.1% |
| FY 2023 | $9.79M | 6 | 2 | +8,533.9% |
| FY 2024 | $13.95M | 12 | 2 | +42.4% |
| FY 2025 | $10.10M | 13 | 2 | −27.6% |
| FY 2026 | -$2.96M | 15 | 2 | −129.3% |
04 / Federal Customers
Which federal agencies buy from NEW YORK GENOME CENTER, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $37.33M | 42 | 98.7% | |
| 3600 | $493.3K | 15 | 1.3% |
05 / Contracting Offices
Which contracting offices buy from NEW YORK GENOME CENTER, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N950 | NATIONAL INSTITUTES OF HEALTH | $22.75M | 12 | 60.1% | |
| 75N920 | NATIONAL INSTITUTES OF HEALTH | $14.23M | 21 | 37.6% | |
| 75N980 | NATIONAL INSTITUTES OF HEALTH | $862.0K | 1 | 2.3% | |
| 36C24E | VETERANS AFFAIRS, DEPARTMENT OF | $493.3K | 15 | 1.3% | |
| 75N910 | NATIONAL INSTITUTES OF HEALTH | -$509.0K | 8 | -1.3% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $23.06M | 20 | 2 | 61.0% |
| 541380 | TESTING LABORATORIES AND SERVICES | $15.13M | 24 | 1 | 40.0% |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $151.0K | 5 | 1 | 0.4% |
| 541990 | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES | -$509.0K | 8 | 1 | -1.3% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| AN11 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $22.71M | 10 | 1 | 60.0% |
| B599 | SPECIAL STUDIES/ANALYSIS- OTHER | $15.09M | 22 | 1 | 39.9% |
| AN41 | HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH | $180.3K | 8 | 1 | 0.5% |
| 6505 | DRUGS AND BIOLOGICALS | $36.2K | 2 | 1 | 0.1% |
| B529 | SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA | -$196.1K | 15 | 2 | -0.5% |
08 / Competition Pattern
How was NEW YORK GENOME CENTER, INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for NEW YORK GENOME CENTER, INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N98026F00001 | Sep 28, 2026 | $862.0K | NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH OLAO | 541380 | B599 |
10 / Interpreting the Profile
How should you evaluate NEW YORK GENOME CENTER, INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.